Compounds found to inhibit HCVpp-1b infection were then counterscreened against pseudoparticles containing the genotype 1a H77C envelope proteins (HCVpp-1a) and pseudoparticles containing the VSV glycoprotein G envelope protein (VSVpp) in order to identify HCVpp-selective inhibitors. The gene discussed is ERVW-1; the disease is infection.